Delivery Order SPE2DB20D7059-SPE2DB24FPWN0

Award Date 1/5/24
Potential Completion Date 1/8/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $40,202.40 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,161,303 units of the ROTARIX vaccine oral syringe, 1.5 mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
This is a $5,859.12 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract does not have a set-aside designation and has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,367.58 contract is for the supply of the ROTARIX vaccine oral syringe 1.5 mL. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,687.66 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide ROTARIX VACCINE ORAL SYRINGE 1.5ML. This award is part of an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The IDC, valued up to...
This is a $10,251.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ROTARIX vaccine oral syringes (1.5mL) and has an ultimate completion date of January 13, 2025. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the ROTARIX vaccine oral syringes in 1.5 mL size. The contract has a potential value of $15,227.75 and a completion date of February 27, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.68 firm fixed-price delivery order is for the supply of ROTARIX vaccine oral syringes, 1.5 mL, to support military healthcare programs. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,900.60 firm fixed-price contract is for the supply of ROTARIX vaccine oral syringes, 1.5 mL in size. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a wide range of pharmaceutical and medical supplies from...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract, SPE2DX15D7067 | SPE2DX24F2YQN, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the ROTARIX vaccine oral syringe 1.5ML. The contract has a ceiling value of $4,394.34 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FPWN0
    Delivery Order

The Defense Logistics Agency has awarded a firm fixed price delivery order worth $7,880.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ROTARIX VACCINE ORAL SYRINGE 1.5ML. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation and is intended to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide. The performance period for this specific delivery order runs through January 8, 2024.

Generated 5/3/24, 9:11 AM